申请人:Sterling Drug Inc.
公开号:US03960886A1
公开(公告)日:1976-06-01
N-Arylanilines, further substituted on nitrogen by aroyl, aralkanoyl or aralkyl groups, and wherein one of the aryl groups has a 3- or 4-(aminoalkoxy)substituent, having hypocholesteremic activity, are prepared by a series of O-alkylation, N-acylation or -alkylation, and reduction reactions starting from the appropriate hydroxydiarylamines or benzyl ethers thereof.
N-芳基苯胺,进一步通过芳酰基、芳基酰基或芳基基团在氮上取代,并其中一个芳基具有3-或4-(氨基烷氧基)取代基,具有降胆固醇活性,通过一系列从适当的羟基二芳胺或其苄基醚出发的O-烷基化、N-酰化或-烷基化和还原反应制备。